glp 1 anorexia nervosa 504: Adult Eating Disorders in the GLP-1 Era Reframing anorexia nervosa as a

Broad use of a hormone prescribed for weight loss has spawned aflurryof menu items touted as GLP-1 friendly, butitsphrase that has no strict definition.

Discover how GLP-1 agonists help improve cardiovascular outcomes independently of glucose control.

Metabolic bariatric procedures, such as sleeve gastrectomy, achieve rapid and clinically meaningful weight reduction, often resulting in improved operative exposure and technical conditions for subsequent resection

These label expansions unlocked new pathways for coverage, and by early 2025 the proportion of Medicare patients with diabetes or obesity initiating GLP-1 therapy rose sharply

A comprehensive program of nutritional and lifestyle counseling is critical to maximize overall efficacy and improve cost-effectiveness of GLP-1s for obesity.